Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole added to prednisolone for first-episode steroid-sensitive idiopathic nephrotic syndrome in children
NL-OMON27331Recruiting
- Sponsor
- Academic Medical Center
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Idiopathic nephrotic syndrome (INS) comparing Levamisole plus prednisolone with Placebo plus prednisolone (2 arms). Primary endpoint: Occurrence of relapse within 12 months after first presentation. Started Mar 2018; status: recruiting.
02
Drugs
levamisoleprednisolone
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on NL-OMON27331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27331.